Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
More than 41,000 medical‑school seniors and recent graduates secured residency positions in the latest match, marking the seventh straight year of growth in the resident workforce. The Association of American Medical Colleges reported a modest rise in active residents for the 2024‑2025 academic year. Meanwhile, the Centers for Medicare & Medicaid Services allocated 400 additional Medicare‑funded slots to 169 teaching hospitals, expanding the federal GME capacity. Legislative and regulatory discussions continue, with over 100 members of Congress urging the Department of Education to preserve post‑graduate training definitions.
At HIMSS26, a dedicated panel examined AI governance alongside the Department of Veterans Affairs’ initiatives to embed artificial intelligence in veteran care. Speakers highlighted how AI tools can streamline clinician workflows, personalize patient interactions, and accelerate decision‑making. The discussion also...
The U.S. Department of Health and Human Services issued a final rule on March 20 establishing a uniform electronic format for health‑care claim attachments under HIPAA, along with mandatory electronic signature requirements. The Centers for Medicare & Medicaid Services projects the...
Four Hatzola volunteer ambulances were set on fire outside the Machzike Hadath synagogue in Golders Green, London. Metropolitan Police have opened a hate‑crime investigation and are examining a claim of responsibility by the extremist group Harakat Ashab al‑Yamin al‑Islamiyya, amid a...
The sterile injectable contract manufacturing market is rapidly evolving as demand surges for both large‑scale biologics and niche, small‑batch therapies. Leading CDMOs are responding by expanding production capacity, building global redundancy, and investing heavily in specialized talent. Development and pre‑commercial...
Harvard researchers published a Cell study showing that mouse skin can fully regenerate by reactivating an embryonic healing program that normally shuts down after birth. They identified excessive nerve growth—hyperinnervation—driven by fibroblast‑derived Cxcl12 as the key barrier to regeneration. Genetic...
Doctors at Liverpool and Cardiff University, together with 20 NHS hospitals, completed a large randomized trial of a rapid procalcitonin‑guided algorithm for suspected sepsis. The study of 7,667 emergency patients showed a 17% relative drop in mortality—from 16.6% to 13.6%—equating...
Scientists at Singapore’s A*STAR Infectious Diseases Labs discovered that tuberculous granulomas persist after standard TB therapy and provide a protected niche for secondary pathogens such as Mycobacterium abscessus. The study, published in Nature Communications, shows that these granulomas shield bacteria...
Keller Rinaudo Cliffton from Zipline thought making the drones would be the hardest part. It was only 15% of the problem. The company spent 9 months figuring out delivery for one hospital. Weeks of all-nighters. Building inventory software in a...
One of the most remarkable things about 5-meo-DMT as an antidepressant is that the psychoactive experience is so brief. 10 minute peak, perhaps. 20 min total. And people seldom remember it well. Yet it has possibly the largest anti-depressant effect...
A Boston University study linked therapist flourishing to lower early client dropout. Each one‑point rise in a therapist’s self‑reported flourishing reduced the odds of a client leaving before three sessions by roughly 10%. Burnout showed no significant effect, while therapist...
Bioengineers embedded soft, stretchable electronics into the tiny clusters to create “cyborg” organoids. These can mimic the pancreas, sensing glucose levels and releasing hormones. They could help build replacement cells for people with type 1 diabetes. https://spectrum.ieee.org/cyborg-stem-cell-therapy-for-diabetes
Healthcare finance leaders are redefining the revenue cycle as a core enterprise capability rather than a back‑office function. In 2026, organizations must align revenue cycle strategy with overall financial goals, adopt AI and predictive analytics under strong governance, and redesign...
A new UCL‑Imperial study finds multiple sclerosis prevalence in England more than doubled between 2000 and 2020, rising from 107 to 232 cases per 100,000—a 6% annual increase. The surge reflects earlier, more accurate diagnoses and longer patient survival thanks...
A multi‑institutional study in the Journal of Clinical Investigation shows that vertical sleeve gastrectomy in adolescents with type 2 diabetes and obesity triggers profound molecular reprogramming of kidney cells, leading to functional recovery. Over a 12‑month follow‑up, participants lost weight, improved...
A recent audit of major children’s hospitals in New Zealand and Australia reveals that sibling‑focused resources are scarce, with only a handful of sites offering material directly aimed at siblings of chronically ill children. In New Zealand, only Starship Children’s Hospital returned...
Acetaminophen, known as paracetamol outside the U.S., is a ubiquitous over‑the‑counter and prescription pain‑relief and fever‑reduction drug. The FDA emphasizes safe use, capping daily intake at 4,000 mg for adults and teens and warning that overdoses can cause liver failure. In...
The World Health Organization has endorsed a new near‑point‑of‑care molecular test that uses a simple tongue swab to detect tuberculosis in under an hour. Developed by PlusLife on its MiniDock platform, the device costs up to 90% less than GeneXpert...
A randomized trial involving 480 seniors at risk for Alzheimer’s tested whether exercise, intensive vascular risk reduction, or their combination could improve cognition over two years. While participants achieved significant cardiovascular gains—blood pressure fell 13 mm Hg and LDL dropped 24 points—the...
A Financial Times analysis of Statista data identifies Europe’s five fastest‑growing pharma and biotech firms between 2021 and 2024. Italy’s Itaste Medical surged to €18.4 billion in sales, a 2,035% absolute growth, while the UK‑based Grow Group expanded cannabis‑based medicines to...
A new meta‑analysis in JAMA Ophthalmology estimates that 21.9 million Americans live with age‑related macular degeneration (AMD), 10 million with diabetic retinopathy (DR), 1.1 million with diabetic macular edema (DME) and 0.9 million with retinal vein occlusion (RVO) as of 2022. Prevalence varies sharply...
In Episode 193 of STEM Talk, neuroscientist Dr. Tommy Wood discusses his new book, *The Simulated Mind*, which challenges the long‑standing belief that adult brains are fixed and inevitably decline. He explains how modern research shows the brain remains plastic...
Asia’s medtech sector is gaining momentum as Singapore became the first nation to achieve the WHO’s highest maturity level for medical‑device regulation, signaling stronger oversight across the product lifecycle. The Financial Times’ 2026 ranking spotlights three leading employers—Baxter International, Medtronic,...
During the first quarter, leading spine surgeons performed a series of first‑in‑human procedures, showcasing new devices and techniques ranging from a standalone ALIF system to augmented‑reality‑guided resections. Notable milestones included Curiteva’s Inspire ALIF, Dymicron’s Triadyme‑C cervical disc, icotec’s CMORE CT...
The Journal of the American Society of Nephrology released new evidence‑based guidance on conservative management for kidney failure, authored by Susan P.Y. Wong and colleagues. The document outlines three core components—customized CKD care, symptom management, and coordinated care transitions—across varying...
The Neuroscience of Vitality and Aging (NOVA) Conference will convene on April 25, 2026 in Boston, bringing together neuroscientists, biotech entrepreneurs, policymakers, and investors for a single‑day interdisciplinary forum. Hosted by the Aging Initiative, the event aims to bridge fragmented...
A prospective study of 38 new wearers of Biofinity silicone‑hydrogel contact lenses found no statistically significant change in corneal sensitivity over the first six weeks of daily use. Measurements taken at baseline, one week, and six weeks showed stable sensitivity...
The medical system thrives on your imposter syndrome. It is not a personal failing. It is a feature of your training. From medical school onward, physicians are conditioned to view uncertainty as dangerous. We are trained to find exactly how we do...
Scientists are investigating selective brain cooling as a proactive defense against altitude sickness, especially high‑altitude cerebral edema. Current treatments—acetazolamide, dexamethasone, supplemental oxygen—have limited efficacy and notable side effects. Cooling helmets and cervical collars can lower brain temperature by up to...
A simple body measurement may predict how long you live. Calf circumference. Muscle is longevity. h/t hyderabaddoctor
Cardiologists’ Knowledge and Compliance With Lifestyle Recommendations For CVD Prevention - American College of Cardiology https://t.co/bJr4ddGVHD #CardioTwitter #physicians #MedEd #cardiologists #health #lifestylemedicine
Researchers at the University of Edinburgh have engineered bacteria to transform PET plastic waste into levodopa, a primary treatment for Parkinson’s disease. By inserting a seven‑gene, four‑step biosynthetic pathway into Escherichia coli, the team converted both industrial PET feedstock and...
Clinicians don’t need more dashboards. They need insight. See what meaningful healthcare data sharing actually looks like 👇 https://t.co/62WYx0HnXu @PointClickCare #VBC #HITSM
Since 1995 the FDA has moved from approving standard opioid products to implementing a comprehensive regulatory regime aimed at curbing misuse and overdose. Key milestones include the 2007 authority to require Risk Evaluation and Mitigation Strategies (REMS), a series of...
The FDA’s Center for Drug Evaluation and Research (CDER) launched the Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) to create a regulatory pathway for emerging manufacturing technologies. FRAME focuses on four priority technologies—end‑to‑end continuous manufacturing, distributed manufacturing (including non‑traditional sites),...
Healthcare organizations are confronting a new wave of shadow IT, now termed shadow AI, where staff adopt generative AI tools without oversight. The article outlines three mitigation strategies: establishing robust AI governance, deploying technical guardrails such as monitoring and sandbox...
BTK inhibitors have become the cornerstone of chronic lymphocytic leukemia therapy, replacing traditional chemotherapy. Brukinsa (zanubrutinib) is a second‑generation irreversible inhibitor that offers high selectivity and strong efficacy in treatment‑naïve or early‑relapse patients, with reduced cardiovascular risk. Jaypirca (pirtobrutinib) is...
Before investing in smarter automation… Fix the data foundation. Why infrastructure beats point solutions → https://t.co/qWIUPgZhYD @MadaketHealth #PayerIT #HITSM
Competency‑based education is reshaping U.S. medical training by challenging the traditional reliance on grades, USMLE scores, and honor societies. Evidence shows these metrics poorly predict resident performance, prompting accreditation bodies to adopt Milestones and entrustable professional activities (EPAs) as more...
Ahuriri District Health is renovating a long‑vacant clinic on Geddis and Longfellow avenues in Maraenui, Napier, to launch new health services aimed at the local Māori community and broader residents. The project stems from the 2008 Waitangi Tribunal settlement that...
Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool https://t.co/g5iOuzkctO
The FDA updated its safety review of recombinant human growth hormone (somatropin) after the French SAGhE study raised concerns about a possible increased risk of death. The agency identified significant design flaws in the study and found no supporting evidence...
A large meta‑analysis of 421,799 Europeans found psychosocial stressors do not increase overall cancer risk. The study examined five psychosocial factors—including perceived support, distress, neuroticism, relationship status and recent loss—across breast, colorectal, lung, prostate and alcohol‑related cancers. No associations emerged...
Missouri’s Medicaid program now offers free doula services to pregnant and postpartum mothers, reaching about 625 participants in its first 15 months. The initiative, championed by bipartisan lawmakers, aims to curb the state’s high maternal mortality rate—70 deaths annually, 80%...
Smart piece by @FenitN about the rewriting of #Covid history. I would add this: A brand new virus meant health officials were making policy based on the info they had at the time, not what we know now. Policy shifts...
Novartis shares rose 1.1% to 116.84 Swiss francs (≈ $127) after Bank of America lifted its target price to 140 francs (≈ $153) from 130 francs (≈ $141). The Swiss drugmaker’s strong year‑to‑date performance has heightened scrutiny of its late‑stage trials, especially remibrutinib...
The integration of artificial intelligence, extended reality (XR) and immersive simulation is redefining how surgeons learn to operate advanced robotic systems. FundamentalXR’s CEO Richard Vincent explains that data‑driven, scalable simulations combined with precise haptic feedback can replicate real‑world procedures in...
Nearly 90% of U.S. medical groups are actively upgrading staff benefits, with 87% planning enhancements—a jump from 56% two years ago. More than half are lowering the full‑time equivalent threshold to 0.5 FTE to broaden eligibility. New offerings include higher...
Medical schools and hospitals are increasingly relying on high‑fidelity simulators—lifelike manikins that can bleed, cry, sweat, and even speak—to train nurses and physicians. These devices, such as the pregnant model "MamaAnne," allow students to practice complex, fast‑changing scenarios without endangering...
